Member Info for Jace86

It's mental. All progress being informed completely.

Next month. Not next year.

We're getting £3.25m and have done the research aspect of the project and you're like "it's gonna drop" 😂

Literally wishing failure.

Already funded to Sept next year on top of what's coming.

Personally wouldn't even expect to need to see funding until then. If we market well in the US first it should fly from there.

Along with AS being in China next year.

With the right news buying in volume won't happen. It'll move so quick that people will get locked out.

It's a buy and hold. The stockbox video was far better than the RNS. The RNS needed to be clearer on what has actually been achieved.

But absolutely right about people taking and running... See it too often. But this is why the RNS needs better wording and aims for the commercial trial so people can put numbers to the value of the test... This helps the mcap grow. A larger mcap them attracts different investors based on risk policy.

It's how much and how often they can manufacture.

It must work otherwise they wouldn't have moved in from the research phase to testing the upscaling and automation platform... It is these he mentioned in the stockbox video about batch coding in order to return revenue. (I've probably explained that poorly).

It's then what can they provide for the portable test as we've not heard on that so much yet.

The recent issue I don't believe is the cause of the drop. They've not had the rise or volume to really sell them at a gain if that was the subscriber(s) preference.

I do wonder if they went to anyone with a longer term interest...? Or to neutralise any position anyone might have had previously that they couldn't really get out of without it?

Do you mean loan agreement if to be used?

It wasn't a single seller.

There are a mixture of things. Mostly bored PI.

Secondly, how much are market markers allowed to hold and what can they do with it without disclosure...

It has and it hasn't.

Is it clear to the market what the company is offering and the stage it's at?

I believe there needs to be more put out there on what the research indicated and how the automation platform works along with the test outcome thats to be expected from the commercial platform.

Currently I don't think the wider market and general public understands specifity and sensitivity on the test itself and how this translates to an outcome. It needs to be in proper layman's terms for people to digest and not buried in the prospectus.

Definitely not. Neither is any of the progress on our test.

The PUT option as far as we are concerned IS our progress on AZD1656.

What do you think the PUT option is...?

I can't tell if you are joking or not Joe...

Finance needs being derisked.

Test works.

MABs optimised.

Automation platform in place.

Moving to large scale testing using that platform.

Then use everything done so far in a small trial and apply for FDA marker. It's a given as work is done before hand and it's not left to chance.

Should be 20p alone. This is no longer a sum of parts valuation (by Hardman). It beyond that.

If the mcap lifts you'll see buyers Widglide. Many have a policy of not buying into firms with a low mcap. The low mcap imo holds us back.

The issue is it isn't a response from the company but a response from PR... Has PR simply got it wrong?

Wid - the project is being supported by many parties. China where AS is next month is supported by Sinopharm and Bosch. Not exactly minnows... What we don't know is who is buying and who is selling. Mainly bored PI selling by the looks of it. Key holders remain holding.

RNS and socials are useless. The video interview with Allan is what we should be paying attention to.

The test works beyond proof of concept. Now it's a case of making it work on a large scale.

Thanks LB. That definitely brings new meaning to the RNS.

I believe a correction or update RNS should be seen. How many don't see stockbox or this BB for clarification?

You mean the iron tablet? It's a prescription drug...

I'd imagine the marketing techniques of both would be far different, no? This is a diagnostic...

I think you are hitting the nail on the head Cymru. That is my exact thoughts on where we are too.

I think this gives a good summary of the steps necessary to move forward.

https://twitter.com/StockBoxMedia/status/1689914277266632704?s=20